Company news

HBM Holdings Ltd. news in 2022

HBM Holdings Ltd.'s news releases, calls and decks from 2022, newest first.

View company

Harbour BioMed Enters into a License and Collaboration Agreement with Moderna

November 10, 2022

Harbour BioMed Appoints Dr. Alexander A. Zukiwski to its Scientific Advisory Board

May 4, 2022

Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022

April 6, 2022

Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities

March 24, 2022

Harbour BioMed Announces Dosing of First Patient of Two Phase I Trials for Next-Generation Anti-CTLA-4 Antibody HBM4003

January 4, 2022

Decks in 2022